Activation of transcription factor circuity in 2i-induced ground state pluripotency is independent of repressive global epigenetic landscapes by Shukla, Ruchi et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Activation of transcription factor circuity in 2i-induced ground
state pluripotency is independent of repressive global epigenetic
landscapes
Citation for published version:
Shukla, R, Mjoseng, HK, Thomson, J, Kling, S, Sproul, D, Dunican, D, Ramsahoye, B, Wongtawan, T,
Treindl, F, Templin, MF, Adams, I, Pennings, S & Meehan, R 2020, 'Activation of transcription factor circuity
in 2i-induced ground state pluripotency is independent of repressive global epigenetic landscapes', Nucleic
Acids Research. https://doi.org/10.1093/nar/gkaa529
Digital Object Identifier (DOI):
10.1093/nar/gkaa529
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
Nucleic Acids Research
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 03. Jul. 2020
Some supplementary files may need to be viewed online via your 
Referee Centre at http://mc.manuscriptcentral.com/nar.
Activation of transcription factor circuity in 2i-induced 
ground-state pluripotency is independent of repressive 
global epigenetic landscapes 
Journal: Nucleic Acids Research
Manuscript ID NAR-03256-X-2019.R2
Manuscript Type: 1 Standard Manuscript
Key Words: DNA methylation, 2i ESC ground state, Uncoupling epigenetics from stem cell pluripotency
 
For Peer Review
Nucleic Acids Research
Serum/LIF 2i/LIF
Global
Establishment of naïve state
 pluripotency transcriptome
Serum enhancers : Active
2i enhancers: Poised
Serum enhancers : Poised
2i enhancers: Active
WT
Dnmt TKO
Constitutive Dnmt
5mC
WT
Dnmt TKO
Constitutive Dnmt
Global
H3K27me3
WT
Dnmt TKO
Constitutive Dnmt
CGI CGI CGI CGI
WT
Methylated Hypomethylated
 Dnmt TKO
No methylationNo methylation
Constitutive 
Dnmt’s (3B3l)
Methylated Methylated
+
+++
++++
++++++
+ ++++
Nanog heterogeneous
Nanog heterogeneous
Nanog heterogeneous
Nanog homogeneous
Nanog homogeneous
Nanog homogeneous
Fkbp6/Dazl
Fkbp6/Dazl
Fkbp6/Dazl
Serum/LIF 2i/LIF
Graphic summarising our major ndings that the 2i induced transition 
of mESCs from serum/Lif (S/L) conditions is not dependent on global 
DNA methylation states. This transition is driven by signal induced 
transcription factor changes. 
Morphological and transcriptional changes are comparable for wild 
type (WT), hypomethylated (TKO) and constitutively methylated (3B3l) 
mESCs to the extent that Fkbp6 and Dazl genes are activated in 2i 
conditions despite having fully methylated promoters in 3B3l mESCs. 
11 Activation of transcription factor circuity in 2i-induced ground state pluripotency is 
2 independent of repressive global epigenetic landscapes
3
4 Ruchi Shukla1,6,*, Heidi K. Mjoseng1,*, John P. Thomson1,*, Simon Kling4, Duncan Sproul1, 
5 Donncha S. Dunican1, Bernard Ramsahoye2, Tuempong Wongtawan3,***, Fridolin Treindl4,5, 
6 Markus F. Templin4,5, Ian R. Adams1, Sari Pennings3** and Richard R. Meehan1**
7
8 1. MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, WGH, University 
9 of Edinburgh, EH4 2XU, UK.
10 2. Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular 
11 Medicine, WGH, University of Edinburgh, EH4 2XU, UK.
12 3. Centre for Cardiovascular Science, Queen's Medical Research Institute, University of 
13 Edinburgh, EH16 4TJ, UK.
14 4. NMI Natural and Medical Sciences Institute, Tübingen University, Reutlingen, Germany.
15 5. Pharmaceutical Biotechnology, Tübingen University, Tübingen, Germany.
16 6. Northern Institute for Cancer Research, Newcastle University, NE2 4HH, UK.
17
18 * These three authors contributed equally to this work.
19 ** Corresponding authors:  Richard Meehan, MRC Human Genetics Unit, Institute of Genetics 
20 and Molecular Medicine, WGH, University of Edinburgh, EH4 2XU, UK, Tel: 0131 651 8500. 
21 Sari Pennings, Centre for Cardiovascular Science, Queen's Medical Research Institute, 
22 University of Edinburgh, EH16 4TJ, UK. 
23 E-mails: Richard.Meehan@igmm.ed.ac.uk and Sari.Pennings@ed.ac.uk 
24  
Page 9 of 100
For Peer Review
Nucleic Acids Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
225 *** Current address: Walailak University, Veterinary College, 222 Thaiburi, Thasala, Nakhon 
26 Si Thammarat 80160, Thailand.
27
28 Running title Decoupling of DNA methylation role in resetting pluripotency circuitry
29
Page 10 of 100
For Peer Review
Nucleic Acids Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
330
31 Abstract 
32 Mouse embryonic stem cells (mESCs) cultured with MEK/ERK and GSK3 (2i) inhibitors 
33 transition to ground state pluripotency. Gene expression changes, redistribution of histone 
34 H3K27me3 profiles and global DNA hypomethylation are hallmarks of 2i exposure, but it is 
35 unclear whether epigenetic alterations are required to achieve and maintain ground state or occur 
36 as an outcome of 2i signal induced changes. Here we show that ESCs with three epitypes, WT, 
37 constitutively methylated, or hypomethylated, all undergo comparable morphological, protein 
38 expression and transcriptome changes independently of global alterations of DNA methylation 
39 levels or changes in H3K27me3 profiles. Dazl and Fkbp6 expression are induced by 2i in all three 
40 epitypes, despite exhibiting hypermethylated promoters in constitutively methylated ESCs. We 
41 identify a number of activated gene promoters that undergo 2i dependent loss of H3K27me3 in 
42 all three epitypes, however genetic and pharmaceutical inhibition experiments show that 
43 H3K27me3 is not required for their silencing in non-2i conditions. By separating and defining 
44 their contributions, our data suggest that repressive epigenetic systems play minor roles in mESC 
45 self-renewal and naïve ground state establishment by core sets of dominant pluripotency 
46 associated transcription factor networks, which operate independently from these epigenetic 
47 processes. 
48
49 Introduction
50 Mouse embryonic stem cells (mESCs) can be derived from the inner cell mass (ICM) of 
51 blastocysts following their in vitro culture (1,2). Culture medium developed for mESCs contains 
52 leukemia inhibitory factor (LIF) in the presence of serum or bone morphogenetic protein 4, which 
53 induces phosphorylation and activation of downstream transcription factors Stat3 and Smad1 
54 (3,4). Cultured mESCs have considerable self-renewing capacity via expression of pluripotency 
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455 genes that maintain their identity; they can contribute to germline chimeras and can differentiate 
56 into all three primary germ layers in vitro (5). Pluripotency in mESCs depends upon the 
57 coordinated action of a gene regulatory network assembled from transcription factors (e.g. Oct4, 
58 Sox2, Nanog: the OSN network), which is subject to modulation by multiple signalling pathways 
59 in response to environmental cues that support self-renewal or initiate differentiation (6,7). Under 
60 serum/LIF (serum) culturing conditions, a fine balance between renewal and pro-differentiation 
61 signals results in populations of mESCs that are heterogeneous and metastable, exhibiting a 
62 dynamic equilibrium in expression states for several pluripotency factors (8). Importantly, during 
63 the process of derivation of mESCs from pre-implantation stage embryos the cells adopt mature 
64 heterochromatin and DNA/histone modifications that deviate from their in vivo ICM counterparts 
65 (9). Overall, the cellular and chromatin identity of mESCs in serum cultures partly resembles that 
66 of ICM cells, epiblast cells and germ cells (10,11).
67 Culturing mESCS in 2i/LIF conditions containing inhibitors of MEK/ERK and GSK3 
68 leads to a more homogeneous population, which more closely resemble ICM cells in terms of 
69 gene expression and epigenetic signatures, termed the naïve ground state (11). Transfer of mESCs 
70 from serum to 2i conditions consolidates developmental naïvety by endowing these cells with 
71 additional pluripotency features (12). These include enhanced Nanog and Klf2 expression and 
72 epigenetic changes, such as global DNA hypomethylation and redistribution of H3K27me3 (a 
73 repressive histone modification mark) from bivalent CpG island promoters (13). It has been 
74 proposed that 2i conversion of mESCs represents a remodelling of the epigenome in concert with 
75 a reconfiguration of the gene regulatory network, which enables unbiased developmental 
76 plasticity (14). 
77
78 Although DNA methylation is essential for the maturation of an embryo, it is striking that 
79 globally hypomethylated mESCs lacking de novo and maintenance cytosine methyltransferases 
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580 cultured in serum grow robustly and self-renew (15-17). TKO (Dnmt3a-/-, Dnmt3b-/-; Dnmt1-/-) 
81 cells express typical markers of pluripotency (Oct4, Rex1, Fgf4 and Nanog) to the same extent as 
82 their wild-type (WT) J1 counterparts, strongly suggesting that DNA methylation is dispensable 
83 for mESC maintenance. Lack of DNA methylation restricts the capacity of these cells to 
84 differentiate into early embryonic stages but is permissive for extraembryonic lineages in vivo 
85 (18). Transcriptional repression associated with DNA methylation is essential for maintaining 
86 somatic cell fates and identity (18,19). In serum cultures, different pluripotent states defined by 
87 high-low expression states of Stella, Nanog and Rex1, respectively, are correlated with the 
88 relative global methylation status of mESCs. This suggests a potential role for DNA methylation 
89 in the generation and maintenance of variability in stem cell populations (8,13,20). However, the 
90 direct contribution of DNA hypomethylation in driving mESCs to a naïve gene expression pattern 
91 is still unclear. In addition, the subsequent global redistribution of repressive H3K27me3 marks 
92 observed in hypomethylated 2i mESCs may be causally required to stabilise and maintain the 
93 ground state, or it may be an indirect consequence of decreased DNA methylation levels (13). 
94
95 To explore the potential contributions of DNA methylation in relation to mESC identity and 
96 stability in serum and 2i cultures, we compared the response of WT mESCs with either 
97 constitutively hypomethylated or constitutively methylated mESCs. We observed a similar 
98 response in cell morphology, attainment of uniform expression of pluripotency genes (Nanog 
99 and Esrrb) and deep silencing of differentiation genes. We identified a set of core 
100 transcriptional changes that occur in the transition to 2i in all three epitypes, suggesting that 
101 these changes affect signalling regulated genes and occur independently of DNA methylation 
102 state in mESCs. In addition, we identified a subset of CpG island genes that undergo signal-
103 induced transcriptional changes that coincide with a depletion of H3K27me3 in all three cell 
104 types under 2i conditions, however, H3K27me3 is not required for their silencing in serum 
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6105 cultured mESCs. Our data suggest that altered patterns of DNA methylation and H3K27me3 do 
106 not define naive state identity, which is primarily dictated by transcriptional and signalling 
107 networks. Instead these epigenetic transitions may be part of dynamic chromatin state changes 
108 prior to differentiation, when epigenetic regulatory mechanisms have a role in defining gene 
109 expression states (21). This general conclusion is in broad agreement with recent work that 
110 studied the impact of PRC2 function in the transition of mESCs to a 2i ground state, in which  
111 loss of Eed (a PRC2 component) to prevent H3K27me3 deposition had a minimal effect on the 
112 2i transcriptome, implying that it is largely dispensable for establishment of the ground state 
113 (22,23). This chimes with our recent work showing that although DNA methylation has a role 
114 in shaping major aspects of PRC directed 3D genome organization in mESCs, this also does not 
115 contribute to maintenance of the 2i ground state (24).
116
117 Materials and methods
118
119 Cell Culture 
120 All cell lines used were generated from male WT J1 mESCs that were originally derived from 
121 the 129S4/SvJae strain, except Dnmt1tet/tet cells, derived from R1 mESCs. mESCs were cultured 
122 in serum conditions as previously described (25,26), except ESGRO LIF (Millipore) was used at 
123 500U/mL for all lines apart from Dnmt1tet/tet mESCs which were cultured at 1000U/mL. WT J1 
124 mESCs were grown on Mitomycin C inactivated SNLP feeder cells in serum cultures, all other 
125 cell lines were grown feeder free on 0.2% gelatin-coated flasks. 2i culturing conditions were as 
126 previously described (25,26); inhibitors were used at 1μM PD0325901 (MEK inhibitor, 
127 Stemgent) and 3μM CHIR99021 (GSK3 inhibitor, Stemgent) and ESGRO LIF was used at 
128 1000U/mL. Doxycycline-inducible Prdm14 overexpressing TKO cells were established by 
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7129 transfecting PB-TET-FlagPrdm14-IRES-Neo, PB-CArtTA Adv, pCAG-Pbase and pGG131 
130 (pCAG-DsRed-IRES-Hygro)(27) into TKO cells using Fugene 6 HD (Promega) followed by 
131 sorting red cells using a BD FACSAria flow cytometer; single cell clones were expanded and 
132 characterised. KOVI-3l and 3B3l mESCs were generated as described in McLaughlin et.al. (25). 
133 Dnmt1tet/tet doxycycline regulateable mESCs were a gift from R. Chaillet lab, for derivation 
134 procedure see Borowczyk et al. (28). Dnmt1tet/tet doxycycline regulateable mESCs were treated 
135 with 10M EPZ6438 (EZH2 inhibitor) for 9 days.
136 siRNA knockdown
137  RNAiMAX (ThermoFisher) was used to transfect 2 x 10^5 mESCs/6 well and 1 x 10^5 mESCs 
138 per 12 well (on coverslips coated with 0.2% gelatin) with 50nM siRNA Tet1 plus 50nM siRNA 
139 Tet2 or 100nM scrambled siRNA (see supplementary information, Table S1 for sequences). 
140 mESCs were cultured post transfection in either serum for 72h or 48h in serum followed by 24h 
141 in 2i; medium was changed every day.
142 Embryoid body differentiation 
143  mESCs were detached with trypsin and spun down prior to resuspension in mESC basal medium 
144 with 20% FCS and plating as 200 cells/20l as hanging drop cultures. After 2 days cells 
145 aggregated and EBs were cultured in suspension in mESC basal medium for 3 days prior to 3-6 
146 days of adherent culture on 0.2% gelatin on glass coverslips. Patches of cardiomyocytes were 
147 recorded, and EBs were fixed with 4% PFA for 15min and stored at 4°C covered in PBS prior to 
148 staining.
149 Differentiation to Epiblast stem cells 
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8150 6 X 104 mESCs / 6 well were seeded in standard serum conditions on human fibronectin 
151 (Millipore, FC010) for 24h and subsequently cultured in EpiSC culture medium supplemented 
152 with N2 (Gibco, 17502048) and B27 (Gibco, 17504044) consisting of a 1:1 mixture of DMEM 
153 F-12 (Thermo Fisher, 21331020) and Neurobasal medium (Thermo Fisher, 21103049), 0.1mM 
154 non-essential amino acids (SIGMA), 2mM L-glutamine, 0.1mM beta mercaptoethanol (Thermo 
155 Fisher), Activin A (Peprotech, 120-14E) at 20ng/mL and FGF2 (R&D systems, 3139-FB) at 
156 10ng/mL. Cells were passaged every 3-5 days with accutase (Gibco, A1110501) and reseeded as 
157 clusters of cells at 4 X 104 cells/ 6 well, which resulted in a stable Epiblast stem cell line after 
158 several passages.
159 RT-qPCR
160 Total RNA was extracted using an RNeasy kit (Qiagen), following manufacturer’s protocol and 
161 using Qiashredder columns (Qiagen) to homogenise the samples and RNase free DNase kit 
162 (Qiagen) to perform DNA digestion. 1µg RNA was converted to cDNA using random primers 
163 (Promega) and Superscript III (Thermo Fisher) following manufacturer’s protocol. qPCR 
164 reactions with gene specific primers (see Table S1) were carried out using SYBR green (Roche 
165 or Thermo Fisher) on a Lightcycler 480 System II (Roche). TBP was used for normalisation; 
166 relative quantification was done by the 2^-dCt method. 3 biological replicates were used for 
167 statistics and standard deviation was calculated to generate error bars following MIQE guidelines 
168 (Table S3). 
169
170 Western blotting
171 Protein was extracted using RIPA buffer (Thermo Fisher) supplemented with protease inhibitor 
172 cocktail (Roche) followed by boiling in 1x LDS sample buffer and 1x reducing reagent (both 
173 Thermo Fisher) for 5 min at 95°C. 30, 15 or 7.5µg of protein was loaded per sample and run in 
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9174 4-12% Bis-Tris gels (Thermo Fisher) in 1x MOPS or MES buffer (Thermo Fisher). Dry blotting 
175 was performed using an iBlot™ device (Thermo Fisher) and PVDF iBlot™ gel transfer stacks. 
176 Membranes were blocked in 0.1% Tween-20 in PBS with 1:10 dilution of western blocking 
177 reagent (Thermo Fisher) for a minimum of 45min at room temperature followed by primary 
178 antibody incubation at 4°C overnight and secondary antibody incubation for 1h at room 
179 temperature (for antibodies and dilutions see; supplementary information, Table S2). HRP 
180 stained Western blots were developed using SuperSignal West Pico Chemiluminescent substrate 
181 (Thermo Scientific) and imaged using an ImageQuant LAS 4000 (GE Healthcare). Near infrared 
182 stained blots were imaged on an Odyssey Fc system (LI-COR, Nebraska, US).
183
184 Immunocytochemistry
185 mESCs on glass coverslips coated with gelatin were stained using standard 
186 immunocytochemistry protocols. Briefly, mESCs were fixed with 4% PFA, 10min and incubated 
187 overnight with primary antibodies (see; supplementary information, Table S2) at 4°C, followed 
188 by incubation with appropriate Alexafluor-conjugated secondary antibodies (Thermo Fisher) at 
189 room temperature for 1h. Nuclei were labelled using DAPI (4’,6-diamidino-2-phenylindole). 
190 Imaging was done using a Zeiss Axioscope 2 microscope with Zeiss optics or a Nikon A1 
191 Confocal system with Zeiss optics. Embryos were stained following procedure previously 
192 described (9). Briefly, blastocyst stage embryos were fixed in 4% PFA overnight at 4°C followed 
193 by permeabilisation in 0.2% Triton X-100 (Sigma-Aldrich) in PBS for 30 min and 2 washes with 
194 PBS-0.01% Tween (Sigma-Aldrich; PBST) prior to blocking with 5% donkey serum (Sigma-
195 Aldrich) in PBST for 2h at room temperature. Primary antibodies (see; supplementary 
196 information, Table S2) were incubated overnight at 4°C in 1% donkey serum in PBS, followed 
197 by 3 washes in PBST. Secondary antibodies conjugated to either FITC or TRITC (Jackson 
198 Laboratories) were used at 1:200 for 1h at room temperature, followed by washes. Samples were 
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10
199 counterstained with DAPI in Vectashield mounting medium (Vectashield). Images were captured 
200 with a Zeiss laser confocal microscope (LSM510 Meta) and LSM software.
201
202 Alkaline phosphatase staining
203 Alkaline phosphatase staining was performed using Alkaline phosphatase staining kit II 
204 (Stemgent) according to manufacturer’s instructions and imaged using a Nikon Eclipse Ti-S 
205 microscope.
206
207 Methylation analysis
208 Genomic DNA was extracted using DNeasy Blood and Tissue kit (Qiagen) following 
209 manufacturer’s protocol or standard phenol chloroform precipitation and eluted in water. DNA 
210 was treated with RNase A/T1 Cocktail (Ambion) overnight at 37°C followed by ethanol 
211 precipitation. Quantitation of 5mC in genomic DNA was done by isocratic high performance 
212 reverse phase liquid chromatography (HPLC) as previously described (29) with the following 
213 alterations. A Dionex UM 3000 HPLC system was used complete with a column chiller, C18 
214 column (250mm x 4.6 mm 5μM APEX ODS, Grace Discovery Sciences), and column guard 
215 (Phomenex). The mobile phase was 50mM ammomium phosphate (monobasic) pH4.1. The 
216 column was chilled to 8C to improve peak separation. Deoxyribonucleotides (dNMPs) were 
217 detected at their extinction maxima using a Dionex 3000 multiple wavelength detector: dCMP, 
218 276nm; 5mdCMP, 282nm. Quantifications were calculated from the area under each peak using 
219 the respective extinction coefficients (dCMP, 8.86 x 103; 5mdCMP 9.0 x 103).
220
221 Bisulfite sequencing
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222 Bisulfite sequencing was carried out as described (30). For details of primers utilised see; 
223 supplementary information, Table S1. Bisulfite conversion of DNA was performed using the EZ-
224 DNA methylation gold kit (ZymoResearch), products were cloned into pGEM-T Easy (Promega) 
225 and minimum 24 clones were picked per condition for plasmid preparation followed by 
226 sequencing using BigDye, version 3.1 chemistry (Thermo Fisher). Bisulfite sequencing DNA 
227 methylation analysis (BISMA) was used to calculate percent methylation in bisulfite sequencing 
228 reads. 
229
230 Agilent Expression Array and data analysis 
231 Total RNA was isolated using RNeasy kit (Qiagen) and Cy3 labelled aRNA was prepared using 
232 an Amino Allyl MessageAmp II aRNA kit (Ambion). Samples were hybridised to SurePrint G3 
233 mouse GE 8x60k microarrays (Agilent) and scanned using NimbleGen MS200 (Roche). Results 
234 were analysed with custom-written scripts implemented in R (http://www.R-project.org). 
235 Differential expression was calculated using the Bioconductor package linear models for 
236 microarray data (limma v3.20.8). P-values were corrected for multiple testing using the 
237 Benjamini-Hochberg test and probes with P < 0.05 were deemed significant. 
238
239 meDIP
240 meDIP was carried out as described (31). In short, 20μg of genomic DNA was diluted in TE to 
241 400ul and sonicated using a Covaris plus sonicator to 150-700bp range with a mean of 300bp. 
242 6μg of fragmented DNA was diluted to 450μl in TE and denatured by incubation in a 
243 thermoshaker for 10min at 99°C. 10% of the sample was taken at this stage as an input fraction 
244 and stored at 4°C. Samples were incubated with 15μl of 5mC antibody (Eurogentec) overnight at 
245 4°C. M280 Dynabeads were used for immunoprecipitation. DNA was purified using a PCR clean 
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246 up kit (Qiagen) and samples were eluted into 20μl; 10μl was subjected to whole genome 
247 amplification using a SEQXE WGA kit (SIGMA) per manufacturer’s instructions, except no 
248 SYBR green was added at the amplification step and samples were amplified for a total of 18 
249 cycles at which point the volume required to get 2.1μg of the lowest sample was the volume used 
250 from each sample for further primer removal and clean up using a PCR clean up kit (Qiagen). 
251 We performed proton sequencing on libraries made from 100ng of DNA per sample, using the 
252 Ion XpressPlus Fragment Library Kit (Thermo Fisher). DNA was end repaired, purified, ligated 
253 to Ion-compatible barcoded adapters (Ion Xpress™ Barcode Adapters 1–96, Thermo Fisher), 
254 followed by nick-repair to complete the linkage between adapters and DNA inserts. The adapter-
255 ligated library was then amplified (10 cycles) and size-selected using two rounds of AMPure XP 
256 bead (Beckman Coulter) capture to obtain fragments of approximately 100–250bp. Samples were 
257 then pooled at a 1:1 ratio and sequenced on an Ion Proton P1 microwell chip (Thermo Fisher).
258
259 RNA sequencing 
260 Total RNA was extracted from mESCs using an RNeasy kit (Qiagen). RNA was analysed using 
261 a bioanalyser and confirmed to be above RIN 9. Samples were treated with DNase (Ambion), 
262 and sample integrity verified on the Agilent Bioanalyser with the RNA Nano-chip. Illumina Tru-
263 seq paired end strand specific sequencing (Illumina, USA) was carried out on a NextSeq-550 
264 sequencer (Edinburgh Wellcome trust Clinical Research Facility, Western General Hospital, 
265 Edinburgh, UK). 500ng of Total RNA underwent ribosomal RNA depletion prior to purification 
266 (EPZ6438 treated Dnmt1tet/tet mESCs) or PolyA-selection (J1, TKO and 3B3l mESCs), 
267 fragmentation, random hexamer cDNA generation and purification with AMPure XP beads 
268 (Beckman-Coulter, USA). Multiple indexing adapters were ligated to ds cDNA with subsequent 
269 hybridisation onto flow cells, and DNA fragment enrichment by 15 cycle PCR for sequencing. 
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270 Completed libraries were quantified by qPCR using the KAPA Illumina Library Quantification 
271 Kit (Illumina, USA) before multiplexing in two equimolar pools and running on two flow cells 
272 on the Illumina NextSeq 550. Resulting FastQ files were mapped to the reference genome 
273 (mm10) using the Tophat alignment tool (V2) on Illumina Basespace software and reads per 
274 kilobase per million (RPKM) scores calculated for each gene. Differential gene expression was 
275 carried out using DEseq with cut offs of Log2 fold change >2 and adjusted P-values <0.05 within 
276 replicates applied. 
277
278 H3K27me3 ChIP-seq
279 ChIP was performed exactly as described (25). Sequencing libraries and Ion proton sequencing 
280 was carried out as described for MeDIP-seq above. For details of antibodies see; supplementary 
281 information, Table S2. 
282
283 High content Western blotting – DigiWest
284 DigiWest was performed essentially as described in Treindl et.al. 2016 (32). Briefly; cell pellets 
285 were lysed in RIPA Buffer containing protease Inhibitor Mix M (Serva), PhosSTOP (Roche 
286 Applied Science) and PMSF (Thermo Scientific), incubated for 30 min on ice and protein was 
287 quantified using a Pierce BCA Protein Assay Kit (Thermo Fisher Scientific). Samples were stored 
288 at -80°C until further use. The NuPAGE SDS-PAGE gel system (Thermo Fisher) was used for 
289 protein separation and blotting; 8µl protein per sample was separated using 4-12% Bis-Tris gels 
290 and transferred onto PVDF membranes (Millipore). For high content Western analysis, the 
291 DigiWest procedure and data analysis was performed as described in Treindl et al. (32). In brief; 
Page 21 of 100
For Peer Review
Nucleic Acids Research
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
14
292 data generated by a Luminex instrument were analysed using a dedicated analysis tool. To 
293 compare different samples, obtained values were normalised to -actin; log2 transformed and 
294 analysed in MEV 4.9.0 software. Two factor ANOVA was performed in which factor 1 was 
295 defined as 2i treatment and factor two as cell type (J1 vs. TKO vs. 3B3l). P-value based on 1000 
296 permutations was set to 0.005 and hierarchical clustering based on Euclidean Distance was 
297 performed. Significant results were plotted in a heatmap. DigiWest data are composed of 96 
298 individual measurements derived from 96 molecular weight fractions per sample and all values 
299 obtained for a given antibody were used to create images that mimic a Western blot image. 
300 Background subtracted Luminex data were scaled to values from 0 and 1 where the highest 
301 measured signal intensity was set to 1. Scaled data were loaded into the MEV 4.9.0 software 
302 package, and a graph was generated by applying a grayscale colour scheme; 0 (white) to 1 (black). 
303 Heatmaps were saved as images and transferred to Photoshop wherein a Gaussian diffusion was 
304 applied with a radius of half the element height. 
305
306 Bioinformatic processing and analysis of meDIP-Seq and H3K27me3 ChIP-seq datasets 
307 i. Mapping and data normalisation.  Analysis was done as described previously (31). In short, 
308 reads were mapped to reference genome using Torrent TMAP software. Data was binned into 
309 200bp windows across the genome and normalised first by total read count and then sequencing 
310 noise removed by subtracting the matched input sequence (sheared non-immunoprecipitated 
311 DNA). 
312 ii. Peak finding and mapping. Windows of enrichment were defined as any 200bp window where 
313 the signal was enriched over background input noise . Peaks of 5mC and H3K27me3 were called 
314 based on threshold levels from J1-serum cells. We defined peaks as regions where at least 2 
315 windows (each 200bp) in a three-window region (600bp) were above the 95th percentile of 5mC 
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316 scores from the J1-serum dataset. These peaks were mapped to one of six unique genomic 
317 compartments (promoter core: TSS +/-100bp, promoter proximal: TSS +1kb, promoter distal: 
318 TSS +1kb to + 2kb, exonic, intronic or inter-genic: not associated with any of the above) as 
319 defined from Refgene annotations.
320 iii. Sliding window analysis of 5mC states over regions of interest. Average patterns of DNA 
321 modifications and histone tail marks were plotted across a series of genomic features (promoters 
322 +/-2kb, gene bodies +/-25% total gene length, Oct4/Sox2/Nanog binding sites +/- 100% element 
323 length) using a sliding window based approach. This calculates average levels of each 
324 modification across a certain step size relative to coordinates of choice and average patterns 
325 across these features are then plotted. Oct4/Sox2/Nanog binding sites were taken as defined in 
326 Galonska et al. (22).
327
328 Retrotransposon analysis
329 J1, TKO and 3B3l mESC RNA-seq was processed as described (25). For retrotransposon 
330 analysis, adaptors were removed from RNA-seq reads using TrimGalore! 0.4.1 (paired end, 
331 illumina, stringency 3), and aligned to the mm9 mouse genome using TopHat 2.1.0 (very 
332 sensitive, inner distance 23 ± 56, no coverage search, max multihits 1). Read co-ordinates were 
333 intersected with UCSC genome browser RepeatMasker track co-ordinates using BEDTools 
334 2.25.0, filtered to ensure that each pair or singleton was assigned to only one repeat location, and 
335 the number of sequences belonging to each type of repeat summed. Repeats belonging to LTR, 
336 LINE and SINE Repeatmasker classes that were significantly upregulated (FDR< 0.05, logFC > 
337 0) were identified using the edgeR package in R. Read counts between samples were normalised 
338 relative to the number of reads mapping to the genome. 
339
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340 Data availability
341 Data generated or used in this study can be found NCBI GEO Series accession numbers: J1 
342 serum/2i MeDIP-seq & 3B3l serum/2i MeDIP-seq: GSM1865089, GSM1865091, GSM2700270, 
343 GSM2700271, GSM1865090 & GSM1865092; WT serum/2i H3K27me3 ChIP-seq GSE23943; 
344 3B3l serum/2i H3K27me3 ChIP-seq: GSM2700276, GSM2700277; TKO serum/2i H3K27me3 
345 ChIP-seq: GSM2700278, GSM2700279, GSM2700284 & GSM2700285; J1, TKO and 3B3l 
346 serum/2i gene expression data (microarray): GSE72302; J1 and 3B3l serum/2i gene expression 
347 (RNA-seq): GSE121171; TKO gene expression (RNA-seq): GSE130686; EPZ gene expression: 
348 GSE101928. DigiWest Luminex reads can be found in; supplementary information, Dataset 2.
349
350 Results
351
352 mESCs reset to a naïve ground state in 2i independently of their initial epigenetic state
353 To investigate the role of repressive epigenetic marks in ground state pluripotency we cultured 
354 WT, hypomethylated, and constitutively methylated mESCs and analysed their response to 2i 
355 conditions. As a hypomethylated cell type we utilised TKO mESCs lacking functional Dnmt3a, 
356 Dnmt3b and Dnmt1 (15). To generate constitutively methylated 2i/mESCs, we utilised 
357 Dnmt3a/3b knockout mESCs rescued by exogenous constitutive expression of Dnmt3b and 
358 Dnmt3l, as detailed in the cell line derivation schematic, hereafter termed 3B3l (Fig. 1a) (25,33). 
359 WT J1, TKO and 3B3l mESCs were cultured in 2i medium for 14 days. All three cell types 
360 showed characteristic mESC morphologies in serum conditions and acquired archetypal three-
361 dimensional dome-shaped colony morphology after 3 days of 2i exposure (Fig. 1b) (26). 
362 Expression of a key marker of 2i transition, Prdm14, was upregulated in all three cell lines (Fig. 
363 1c) (34). In WT JI mESCs Transcripts corresponding to de novo methyltransferases (Dnmt3a, 
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364 Dnmt3b and Dnmt3l) were downregulated while the maintenance methyltransferase (Dnmt1) 
365 remained unchanged, as observed by microarray analysis and confirmed by RT-qPCR (Fig. 1c 
366 and S1a). As expected, only the Dnmt3l transcript was downregulated in TKO cells, as the 
367 Dnmt3a, Dnmt3b and Dnmt1 genes are inactivated. In addition, we confirmed retention of 
368 Dnmt3b and Dnmt3l transcripts in 3B3l mESCs (Fig. 1c and S1b). We also detected 
369 homogeneous expression of Nanog and Esrrb in WT J1, TKO and 3B3l mESCs cultured in 2i by 
370 immunocytochemistry, in contrast to heterogeneous staining in their serum cultured counterparts 
371 (Fig. 1d). 
372 To analyse changes in DNA methylation in WT J1, TKO and 3B3l mESCs when 
373 converted to a 2i mediated ground state, we performed high performance liquid chromatography 
374 (HPLC) quantification of total 5mC levels, which revealed various degrees of hypomethylation 
375 in 2i (Fig. 1e). As reported previously, 5mC levels in 2i are reduced by 50% in WT mESCs (J1-
376 2i) (Fig. 1e). Notably, 3B3l cells cultured in 2i (3B3l-2i) exhibited global DNA methylation levels 
377 equivalent to WT J1-serum cells (Fig. 1e). Hence, maintenance of Dnmt3b and Dnmt3l 
378 expression can prevent cells from exhibiting global hypomethylation despite increased Prdm14 
379 levels during 2i adaptation (Fig. 1c and S1b). Loss of DNA methylation upon 2i exposure is 
380 linked with Prdm14 directed repression of Dnmt3a/Dnmt3b/Dnmt3l or alternatively, a deficiency 
381 of UHRF1 and H3K9me2, required for maintenance methylation (35-37). Although we observed 
382 the reported 2i induced reduction of UHRF1 and H3K9me2 levels in WT mESCs that is 
383 hypothesised to reduce Dnmt1 activity, these alterations were not replicated in TKO-2i or 3B3l-
384 2i mESCs (Supplementary information, Fig. S1c, d) (35). The observation that overexpression of 
385 Dnmt3b and Dnmt3l (or deletion of Prdm14, see below) can maintain methylation levels in 2i 
386 mESCs is incompatible with the primary role proposed for UHRF1 in regulating global DNA 
387 methylation levels in 2i mESCs (35,36). Bisulfite sequencing analysis of loci (major satellite, 
388 Dazl and Fkbp6 promoters) known to undergo hypomethylation in 2i demonstrated that 3B3l-2i 
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389 methylation was maintained at most of these sites (major satellite, Dazl) or underwent a slight 
390 decrease (Fkbp6 10% decrease, p < 0.05, 2-tailed Mann-Whitney U-Test), but still remained 
391 significantly more highly methylated than in J1-2i cells (Fkbp6 75.3% in 3B3l-2i compared with 
392 19.7% in J1-2i, p < 0.00001, 2-tailed Mann-Whitney U-Test) (Fig. 1f). 
393 To further characterise WT J1, TKO and 3B3l mESCs cultured in 2i we performed several 
394 experiments to confirm their pluripotency and 2i mediated signalling responses. All three 
395 epitypes exhibit heterogeneous alkaline phosphatase activity in serum and this increases to 100% 
396 homogeneous alkaline phosphatase activity in mESCs cultured in 2i (Supplementary information, 
397 Fig. S1e). To analyse changes in signalling pathways following 2i culture we utilised the western 
398 blotting analysis system DigiWest to simultaneously assay 72 proteins (32). This confirmed the 
399 absence of Dnmt1 protein in TKO mESCs and maintenance of Dnmt3l in 3B3l-2i at levels 
400 significantly above J1-2i and TKO-2i (Supplementary information, Fig. S1f). As expected, 
401 culturing mESCs in 2i resulted in upregulation of -catenin, one of the downstream targets of the 
402 GSK3 pathway and downregulation of phospho-c-Myc, a downstream target of the MEK 
403 pathway (Supplementary information, Fig. S1f) (26). Hence, relevant signalling pathways are 
404 intact in all three cell lines utilised in the study. Several other proteins exhibit similar expression 
405 changes in WT J1, TKO and 3B3l mESCs based on culture conditions e.g. vimentin, which may 
406 account for changes in cell shape during 2i adaptation (Supplementary information, Fig. S1f). 
407 Moreover, ANOVA analysis of significant analytes (P < 0.005) resulted in clustering of DigiWest 
408 samples according to culture conditions (Supplementary information, Fig. S1g, Dataset 2); 
409 implying that signal transduction pathways that respond to 2i in WT J1, TKO and 3B3l mESCs 
410 induce similar protein expression and modification perturbations. In addition, we found that J1 
411 and 3B3l mESCS were capable of forming differentiated embryoid body (EB) outgrowths when 
412 plated onto gelatin. TKO mESCs formed EBs but failed to form significant outgrowths and very 
413 few cells stained positive for α-smooth muscle actin (mesodermal marker) and Tuj1 (ectoderm) 
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414 (Supplementary information Fig. 2a and data not shown). This is in agreement with previous 
415 observations that lack of DNA methylation in TKO mESCs leads to impaired differentiation to 
416 ecto- and mesoderm (18). WT J1 and 3B3l mESCs formed ectoderm and mesoderm lineages; 
417 both generated beating cardiomyocytes staining positive for -smooth muscle actin, as well as 
418 cells positive for Tuj1 (Supplementary information, Fig. S2b). It is note-worthy that the 
419 α−smooth muscle actin marker not only reports on a mesodermal lineage but also attests the 
420 earliest differentiation from pluripotent mouse ESCs into mesendoderm, (ME) the intermediate 
421 stage equivalent to the embryonic primitive streak, from which both mesoderm and endoderm 
422 are derived (38). However, we did not observe significant endodermal marker expression for 
423 either cell type with this differentiation protocol; perhaps indicating that a more directed 
424 differentiation approach may be required to generate this lineage with these cell lines (data not 
425 shown). In addition, WT J1 and  3B3l mESCs both  generated a stable epiblast stem cell line 
426 when treated with appropriate cytokines, however TKO mESCs were unable to differentiate to 
427 this lineage (Supplementary information, Fig. S2c). Taken together this data suggests that 3B3l 
428 mESCs can transition to a naive ground state and differentiate into specialised cell types unlike 
429 TKO cells, which are differentiation impaired.
430 In order to investigate alterations in repressive chromatin marks in response to DNA 
431 methylation changes and 2i signalling we performed immunocytochemistry (ICC) for 
432 H3K27me3 and H2AK119ub in WT J1, TKO and 3B3l mESCs cultured in serum and 2i, as well 
433 as in early and late blastocysts. As reported previously, both H3K27me3 and H2AK119ub are 
434 redirected to pericentric heterochromatin (PCH) in a high proportion of TKO cells under serum 
435 conditions (Fig. 2a) (39). A similar proportion exhibited PCH localisation for both modifications 
436 in TKO-2i cells (Fig. 2a). In contrast, no significant PCH association of H3K27me3 and 
437 H2AK119ub was observed in J1-2i or 3B3l-2i cells (Fig. 2b; Supplementary information, Fig. 
438 S3). This contrasts with a recent report suggesting that 2i-ESCs are distinguished from other 
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439 pluripotent cells by a prominent enrichment in H3K27me3 and low levels of DNA methylation 
440 at PCH (40). However we note that Tosolini and colleagues culture their 2i-mESCs on Laminin 
441 which also leads to the appearence of H3K27me3 in conjunction with H3K9me3 at PCH in serum 
442 grown mESCs, whereas we follow the original SOP of Ying et al., 2008 and grow ESCs on gelatin 
443 coated plastic (26). It is possible that the ability of Lamins to confer proliferative stimulation on 
444 mESCs may cause additional changes that affect H3K27me3 deposition when mESCs are 
445 transitioned to 2i (41). To verify the situation in vivo, we isolated blastocyst stage embryos and 
446 stained them for H3K27me3 (9). Early and late male blastocysts show a marked increase in 
447 H3K27me3 levels in the ICM, in contrast to very low trophectoderm (TE) levels (Fig. 2c). Early 
448 ICM patterns display euchromatic distribution away from DNA-dense foci similar to WT J1 
449 mESCs. This pattern is maintained in the epiblast; however, in some cells of the late ICM margin 
450 proximal to the blastocoele, H3K27me3 foci colocalise with regions of high DNA density in a 
451 pattern similar to TKO cells (Fig. 2c). This indicates redistribution of H3K27me3 might be a 
452 response to developmental cues that involves DNA hypomethylation of the ICM (42,43).  During 
453 the meiotic prophase of spermatogenesis, H3K27me3 is also observed to accumulate on PCH 
454 from the mid pachytene stage onward, during which DNA methylation reprogramming occurs as 
455 evidenced by hyomethylated minor satellite repeats (44,45).
456
457 Inhibition of MEK1/2 and GSK3 is necessary to drive TKO cells to the naïve state
458 As a reduction in DNA methylation has been postulated to be a hallmark of the naïve state, we 
459 analysed TKO mESCs to address whether they would convert more easily to the ground state 
460 than WT mESCs. We checked the sensitivity of J1 and TKO cells to the two inhibitors at various 
461 dilutions in defined media (SFES) with a constant LIF concentration. Both cell lines responded 
462 comparably and neither achieved ground state morphology when cultured in diluted 2i medium 
463 (Supplementary information, Fig. S4a). We observed comparable trends in key transcript changes 
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464 in both J1 and TKO mESCs in diluted 2i, but alterations were not to the same extent as in 
465 complete 2i (Supplementary information, Fig. S4b). We also evaluated the effect of individual 
466 inhibitors, PD0325901 and CHIR99021. TKO cells acquired a 3D-dome shaped colony 
467 morphology similar to 2i adaptation, upon exposure to CHIR99021 + LIF (CH), while exhibiting 
468 very distinct needle-shaped flat cell morphology upon PD0325901 + LIF (PD) treatment 
469 (Supplementary information, Fig. S4c-d). Nanog expression was lower in TKO cells incubated 
470 with CH alone compared to PD or 2i cultured cells (Supplementary information, Fig. S4e). 
471 Prolonged culture in no inhibitor medium (SFES) or single inhibitor (CH or PD) resulted in 
472 decreased cell viability and spontaneous differentiation compared to 2i cells, in agreement with 
473 reports for WT cells (Supplementary information, Fig. S4d) (26). Associated gene expression 
474 changes (notably Dnmt3l, Eomes and Lin28a) did not occur to the same extent with single 
475 inhibitors as compared to inhibiting both pathways (Supplementary information, Fig. S4f). 
476 As Prdm14 is suggested to be a key player in driving cells to the 2i ground state, we 
477 generated a TET-inducible Prdm14 TKO mESC line to test if its overexpression in 
478 hypomethylated mESCs is sufficient to drive these mESCs into a ground state (Supplementary 
479 information, Fig. S5a-b) (36). Upon induction of Prdm14 no morphological changes were 
480 observed in TET-ON-Prdm14 TKO clones (Supplementary information, Fig. S5c). Additionally, 
481 although direct targets of Prdm14 such as Dnmt3l and Lefty2 were down regulated, we did not 
482 observe transcript changes associated with 2i adaptation such as upregulation of Dmgdh (highest 
483 expression change in 2i versus serum in wild-type mESCs) or Eomes (stem cell maintenance 
484 gene) and downregulation of Pax6 and Fgf15 (differentiation genes), in any of the TET-ON-
485 Prdm14 TKO clones irrespective of the level of Prdm14 overexpression (Supplementary 
486 information, Fig. S5d) (46). This suggests Prdm14 upregulation and 5mC depletion alone is not 
487 sufficient to reprogram serum cultured mESCs to a ground state in terms of morphology 
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488 (Supplementary information, Fig. S5c) or gene expression (Supplementary information, Fig. 
489 S5d). 
490
491 Gene expression patterns are determined by culture conditions 
492 In order to delineate gene expression changes caused by 2i signalling from gene expression 
493 changes caused by a difference in DNA methylation, we analysed gene expression in WT J1, 
494 TKO and 3B3l mESCs cultured in serum and 2i. Pearson correlation analysis of expression 
495 profiles revealed robust clustering based on culture conditions rather than genotype (Fig. 3a). The 
496 number of differentially expressed genes between TKO and WT J1 mESCs in 2i compared to 
497 serum culture conditions is reduced and consolidates as 3.3 times less upregulated and 2.9 times 
498 less downregulated genes (Supplementary information, Fig. S6a, b). Moreover, in spite of being 
499 hypomethylated in 2i, the transcriptome of WT J1-2i mESCs differs greatly from that of TKO-
500 serum (Supplementary information, Fig. S6c). In agreement with previous reports, we observed 
501 a large number of genes (>3500) differentially expressed in 2i wild-type cells compared to serum 
502 conditions (1823 up- and 2208 down- regulated, fold change ≥ 2, p.adj. ≤ 0.05, eBayes (limma), 
503 Benjamini-Hochberg corrected) (Fig. 3b; Supplementary information, Dataset 1) (13,36,47). 
504 There is an overlap of 843 genes between all three 2i cell lines that exhibited similar changes in 
505 expression (318 up- and 525 down-regulated) (Fig. 3b; Supplementary information, Dataset 1). 
506 Moreover, transcription factors associated with naïve pluripotency are upregulated in WT J1, 
507 TKO and 3B3l in 2i compared to respective serum cells; with the exception of Klf2 which 
508 exhibited increased expression in TKO and 3B3l mESCs in serum (Fig. 3c). Importantly, these 
509 factors are equivalently expressed in all three epitypes in 2i. Functional pathway analysis of the 
510 common gene list upregulated in 2i revealed enrichment of genes related to germ cell and 
511 embryonic development, while genes downregulated in 2i are linked with differentiation (Fig. 
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512 3d). Based on pathway analysis, we focused on genes associated with the GO terms ‘Cell Fate 
513 Commitment’ (CFC: GO:0045165) and ‘Stem Cell Maintenance’ (SCM: GO:0019827), which 
514 were differentially expressed (FC  1.5, p.adj < 0.05, eBayes (limma), Benjamini-Hochberg 
515 corrected) between WT J1-serum and J1-2i mESCs. These gene sets showed a similar trend in 
516 TKO and 3B3l mESCs following adaptation to 2i (Fig. 3e, f; Supplementary information, Fig. 
517 S6d and S7) and we also observed this in WT and Prdm14-/- mESCs, (Supplementary 
518 information, Fig. S6e, f) (36) . In addition, hierarchical clustering analysis linked these cell types 
519 together based on culture condition rather than genotype (Supplementary information, Fig. S6g). 
520 Our results emphasise that mESCs can achieve a “transcriptional ground state” in 2i through 
521 enhanced expression of a number of pluripotency associated genes, including Nanog, Esrrb and 
522 Klf4, irrespective of global methylation status, and that hypomethylation is dispensable for this 
523 transition (Fig. 3f). 
524
525 Epigenetic changes in the 2i mediated ground state 
526 To study functional consequences of DNA methylation rearrangement in the reprogramming of 
527 mESCs to ground state, we generated genome-wide patterns of 5mC in WT J1 and 3B3l mESCs 
528 cultured in serum and 2i by genome wide MeDIP-seq assays (31). We validated the levels of 
529 5mC enrichment across the genome in J1 and 3B3l epitypes and report upon an approximately 
530 50% reduction in the number of both 5mC enriched loci (termed windows, see material and 
531 methods) and HPLC quantified 5mC scores in J1-2i mESCs (Fig. 1e and Fig. 4a). The number of 
532 enriched windows in 3B3l-serum was similar to those in WT J1-serum; as expected this cell line 
533 did not exhibit the typical loss of 5mC upon 2i exposure (Fig. 4a). Interestingly, although global 
534 levels of 5mC differ between the epitypes upon transition to ground state, by western blot there 
535 was no obvious change in total H3K27me3 levels in WT J1 and 3B3l mESCs in serum or 2i in 
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536 agreement with two reports, but H3K27me3 levels were higher in TKO-2i cells (Fig. 4b) (13,40). 
537 In contrast,  a recent proteomic study found higher H3K27me3 levels in WT mESCs cultured in 
538 2i conditions; despite this they also report, by ChIP-seq,  a redistribution of H3K27me3 profiles 
539 in 2i culture conditions (23). Although we report an overall reduction in 5mC levels within these 
540 cells (as evident from a drop of 5mC peaks to 4.7% in the J1-21 cells with respect to the serum 
541 state. Fig. 4c), the underlying genomic patterns remain largely unchanged (Fig. 4d; 
542 Supplementary information, Fig.  S8a, b)
543
544 To refine our assessment, we interrogated 5mC and H3K27me3 patterns across a number 
545 of functional genomic compartments (Fig. 4). Focusing first on promoter and gene body regions, 
546 we discovered that although levels and patterns of 5mC are lost upon transition to 2i in WT J1 
547 cells, these are maintained across the same sets of promoters and gene bodies in J1-serum, 3B3l-
548 serum and 3B3l-2i mESCs (Fig. 4a and 4c-e). Analysis of locus specific patterns also revealed 
549 that 5mC marked promoters identified in WT J1 serum mESCs remain similarly marked in both 
550 3B3l-serum and 2i cells (Fig. 4d, e). To analyse H3K27me3 patterns we utilised a published E14 
551 mESC dataset as our WT reference data (GSE23943) as their deposition at bivalent promoters is 
552 reported to be dependent on global DNA methylation levels  (13,43,48). H3K27me3 patterns are 
553 typically reduced upon transition to 2i in WT E14 mESCs but broadly maintained over promoter 
554 and genic regions in the constitutively methylated cell line in 2i (Fig. 4d, f). To delineate 5mC 
555 mediated changes from 2i signalling changes in H3K27me3 distribution; we compared patterns 
556 of H3K27me3 between TKO-serum and TKO-2i mESCs. Interestingly we note a reduction in the 
557 H3K27me3 signal, which manifests in loss from a number of promoter elements (Fig. 4f, g). 
558 Stratification of the total promoter set based on regions which lose H3K27me3 between TKO-
559 serum and TKO-2i revealed a subset of 2i specific, DNA methylation independent regulation loci 
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560 across all epitypes (Fig. 4f). Visualisation of these loci (specific examples; Neurog3, Hoxc12-13 
561 and Tbx3) uncovered a strong loss of H3K27me3 levels in 2i conditions irrespective of global 
562 DNA methylation state – highlighting a small set of common 2i signalling induced epigenetic 
563 changes in all three mESC epitypes (Fig. 4h). 
564 Analysis over enhancer and pluripotency factor binding elements revealed that such loci 
565 are typically depleted in 5mC and H3K27me3 in both serum and 2i conditions for all three 
566 epitypes (Fig. 4d; Supplementary information, Fig. S8b) (22). Analysis over annotated replication 
567 origin sites revealed a general loss of 5mC in WT J1-2i conditions but higher levels of 5mC at 
568 medium and late replicating sites in both WT J1-serum, 3B3l-serum and 3B3l-2i mESCs (Fig. 
569 4d) (49). Similarly, there is a general loss of H3K27me3 in WT E14-2i cells with higher levels 
570 of H3K27me3 present in early replication origins in WT E14-serum, 3B3l-serum and 3B3l-2i 
571 lines (Fig. 4d). Additionally, DNA methylation is lost at repeat sequences (including major 
572 satellite and LINE-1 retrotransposons) in WT J1-2i but maintained in 3B3l-2i mESCs (Fig. 4d). 
573 Analysis of RNA-seq data for WT J1, TKO and 3B3l mESCs cultured in serum and 2i 
574 revealed that some differences exist between culture conditions and epitypes tested in terms of 
575 retrotransposon expression (Supplementary information, Fig. S8c-f). Consistent with previous 
576 observations, retrotransposon derepression in response to 2i or changes in DNA methylation was 
577 relatively modest in mESCs (Supplementary information, Fig. S8c), and smaller in magnitude 
578 than observed for differentially expressed genes (50-52). A subset of 44 (28%) of the 156 
579 retrotransposons upregulated when WT J1 mESCs transition from serum to 2i is also upregulated 
580 when TKO and 3B3l mESCs transition from serum to 2i (Supplementary information, Fig. S8d). 
581 These retrotransposons, which include RLTR13B2::ETNERV3-int and RLTR44C::RLTR44-int 
582 long terminal repeats and associated internal sequences, are upregulated in 2i regardless of 
583 methylation state (Supplementary information, Fig. S8f). Some elements in this subset, such as 
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584 RLTR10D::IAP-d-int, appear to exhibit a combinatorial response to 2i and DNA methylation 
585 such that they are upregulated in response to hypomethylation and further upregulated in response 
586 to 2i (Supplementary information, Fig. S8f). These elements exhibit similar behaviour to Dazl 
587 and Fkbp6 genes (Fig. 5b), although it is also possible that the mixed response of these elements 
588 reflects distinct responses of individual genomic copies of that repeat. Interestingly, most (149 of 
589 203) of the retrotransposons that are upregulated in response to DNA hypomethylation in serum-
590 cultured mESCs, including RLTR44B and MMERVK10D3_LTR, are not upregulated when WT 
591 J1 mESCs transition from serum to 2i (Supplementary information, Fig. S8e-f). Thus, different 
592 retrotransposons respond to the 2i environment, changes in DNA methylation, or a combination 
593 of both in mESCs. Finally, imprinted loci exhibit a greater level of both 5mC and H3K27me3 
594 retention during 2i reprogramming in both WT J1 and 3B3l mESCs, arguing that maintenance of 
595 5mC levels may be functionally required at such sites (Fig. 4d).
596
597 Analysis of epigenetic changes over transcriptionally altered genes.
598 As we observed a consistent change in transcription in all three epitypes when converted to 2i 
599 mediated ground state, we set out to elucidate whether specific changes to 5mC and H3K27me3 
600 may be fundamental drivers of these changes. For the total arrayed gene set for all three cell types 
601 as well as for gene sets exhibiting strong changes in gene expression when cultured in 2i versus 
602 serum, we did not detect a relationship between alterations in promoter 5mC levels and the 
603 expression status of linked genes (Fig. 5a & Supplementary information, Fig. S9a). To validate 
604 this result, we selected two candidate methylation regulated genes; Dazl and Fkbp6, and 
605 examined the effect of 2i signalling on their expression in WT J1, TKO and 3B3l mESCs by RT-
606 qPCR (Fig. 5b) (13,53). These two transcripts are highly upregulated in TKO compared to WT 
607 J1 mESCs, supporting a role for promoter demethylation in their upregulation. However, they are 
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608 both further upregulated in 2i in TKO and 3B3l mESCs and we observed comparable changes in 
609 Dazl protein levels by DigiWest analysis (Fig. 5b and Supplementary information, Fig. S9b). The 
610 promoters of these genes exhibited demethylation in WT J1-2i but maintained DNA methylation 
611 in 3B3l-2i as evidenced by meDIP and locus-specific bisulfite sequencing (Fig. 5b and 1f). 
612 Hence, at transcript level, regardless of whether their promoters were hypomethylated or 
613 hypermethylated, both Dazl and Fkbp6 responded in the same way to 2i signalling, resembling 
614 what we observed for a subset of 2i mediated changes in DNA repeat expression (Fig. 5b and 
615 Supplementary information, Fig. S8c-f). 
616 We did observe a relationship between loss of H3K27me3 from genic regions of genes 
617 transcriptionally induced in 2i in all three epitypes; a relationship which was not observed over 
618 transcriptionally repressed genes (Fig. 5c). To test whether these genes are regulated by 2i 
619 mediated signalling, we assayed their expression levels in mESCs with altered H3K27me3 levels; 
620 mESCs exposed to an inhibitor of the polycomb protein, EZH2 methyltransferase (EPZ6438), or 
621 through analysis of published expression data from polycomb regulatory complex mutant mESCs 
622 (Eed-/-) (54,55). We found that 2i induced genes, which lost H3K27me3 in WT, 3B3l and TKO 
623 mESCs, were not induced in these H3K27me3 perturbed serum cultured cells (Fig. 5d; 
624 Supplementary information Fig. S10), indicating that changes in expression of these genes are 
625 also direct consequences of 2i signalling and not due to changes in H3K27me3 deposition.
626
627 Relationship between gene regulatory network and epigenetic landscape
628 A recent study has shown that the differential binding of a core network of the pluripotency 
629 factors Oct4, Sox2 and Nanog (OSN) is important in reaching ground state following 2i exposure 
630 (22). However, it is not known how the epigenetic landscapes at these key regulatory sites are 
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631 related to factor binding events and establishment of specific gene regulatory networks. We first 
632 set out to elucidate how the transcriptional landscape at genes near differentially bound OSN sites 
633 is affected during 2i transition by identifying the nearest neighbouring gene (first gene within 
634 10kb of an elevated or reduced OSN site in 2i, referred to as distal elements) and analysed their 
635 expression changes in our cell panel. We discovered a similar number of distal genes that are 
636 induced and repressed near 2i specific OSN sites upon 2i conversion but observed a large 
637 reduction in transcription at distal genes where OSN factors are reduced in 2i, arguing that 
638 transcription from a subset of genes is linked to binding of distal factors (Fig. 6a and 
639 Supplementary information, Fig. S11a). When we rank 2i driven changes in gene expression at 
640 these distal genes in WT J1 mESCs (i.e. log2 FC J1-serum > J1-2i, Fig. S11a), we observe similar 
641 transcriptomic changes following 2i conversion in WT J1, 3B3l and TKO mESCs (Fig. 6a, 
642 Supplementary information, Fig. S11a, b). 
643 Enhancer elements and OSN binding sites are typically DNA hypomethylated, including 
644 in 3B3l mESCs. We therefore tested the hypothesis that active DNA demethylation could play a 
645 key role in the maintenance of this epigenetic state and that if perturbed would affect 
646 constitutively methylated mESCs to a greater degree than WT cells, potentially abrogating their 
647 ability to reach ground state. To do so we used an siRNA approach to reduce the levels of the 
648 DNA demethylation machinery members Tet1 and Tet2 in WT J1 and 3B3l mESCs cultured in 
649 serum or for 24h in 2i (see methods). Compared to scrambled siRNA controls, transfection of 
650 published siRNAs against Tet1 and Tet2 (Supplementary information, Fig. S11c) was sufficient 
651 to reduce the 5hmC signal in these cells to undetectable levels by immunocytochemistry (Fig. 
652 6b) (56). This did not interfere with cell viability as evaluated by morphology, Esrrb staining or 
653 pluripotency marker expression assessed by qRT-PCR, indicating the 5hmC pathway was not 
654 required for the serum to 2i transition in WT J1 and 3B3l mESCs (Fig. 6b, c). 
655
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656 Discussion 
657 In this paper we address some widely held assumptions regarding the epigenetic identity of 
658 ground state ES cells (57). Early observations reported that the transition of ES cells to ground 
659 state, dependent on ground state promoting signalling pathways, is accompanied by a reduction 
660 in DNA methylation levels (20,34). This major epigenetic state change, which also involves 
661 altered H3K27me3 deposition, was viewed as integral to the cells functional transition through 
662 gene expression changes (13). Surprisingly, however, this premise had not been fully tested. Our 
663 study reports three unexpected important new insights: the reduction in DNA methylation is not 
664 a prerequisite for ES cells to achieve the ground state transition; this global DNA 
665 hypomethylation does not lead to transcription alterations of the genes undergoing 
666 demethylation; and H3K27me3 redistribution induced by the reduction in DNA methylation does 
667 not lead to transcription changes of the genes affected, which are dependent on changes in 
668 transcriptional factor networks (22). Our conclusions obtained by a novel route of comparing 
669 serum to 2i transitions of wild type, hypomethylated and constitutively DNA methylated mESCs, 
670 are in alignment with work using PRC2 deficient mESCs that defined 2i induced transcription 
671 factor and proteomic changes respectively (22,23). These papers showed that PRC2 function is 
672 not required for mESC pluripotency, self renewal and the 2i transition. Significantly Van Mierlo 
673 et al.  also observe in 2i cultured PRC2 deficient mESCs  a relative increase in DNA methylation 
674 levels that appears to be due to enhanced protein expression of Dnmt3a, Dnmt3b and Dnmt3l 
675 (23). This observation again challenges the view that it is perturbation of the Dnmt1/Uhrf1 axis 
676 that is responsible for hypomethylation in 2i cultured mESCs (35). Consistent with a direct impact 
677 of PRC2 deficiency on DNA methylation levels in 2i cultured mESCs, hypermethylation is also 
678 observed at the CGI shores of a distinct class of bivalent genes in serum/LIF cultured PRC1/2 
679 mutant mESCs (43). This implies that DNA methylation and Polycomb, two distinct epigenetic 
680 repression systems, have direct as well as indirect impacts on each other. Collectively our data 
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681 and data from Van Mierlo et al. and Galonska et al. support the view that during the 2i transition 
682 changes in H3K27me3 and/or DNA methylation are secondary effects, which do not influence 
683 specific gene expression in 2i mESCs (22,23). These conclusions raise the question to what extent 
684 the epigenetic state of a cell defines its identity. In the case of embryonic stem cells the answer 
685 points to an epigenetic ground state that is decoupled from the pluripotency ground state, with 
686 both the gene regulatory network and the epigenetic network poised to interconnect at or after 
687 differentiation. Of relevance here is the previous suggestion that enhanced germline gene 
688 expression in ground state mESCs is primarily a consequence of global DNA hypomethylation 
689 (50). We tested this premise and found that patterns of gene expression including germline, are 
690 similarly dependent on 2i culture conditions, and occur independently of DNA methylation 
691 status. Our observations imply that global reduction of 5mC is not required for gene regulatory 
692 networks to orchestrate changes in transcription resulting in altered stem cell states. This is in 
693 line with the observation that in some species extensive reprogramming of DNA methylation in 
694 early embryogenesis is not observed (58,59). 
695
696 H3K27me3 regulated gene expression
697 All three mESC epitypes showed similar morphological changes, enhanced expression of 
698 pluripotency factors and signalling induced changes at a discrete set of H3K27me3 marked genes 
699 (e.g. Tbx3, Hoxc12 and Hoxc13). Notably, expression of these H3K27me3 marked genes was not 
700 activated in serum in the absence of polycomb repression. This agrees with our recent work on 
701 the identification of DNA methylation mediated changes in chromatin compaction that occurs 
702 when WT mESCs are shifted from serum to 2i growth conditions (25). Chromatin decompaction 
703 at polycomb marked regions is prevented in 3B3l-2i mESCs when global DNA methylation is 
704 maintained, but inhibition of decompaction also does not appear to have phenotypic 
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705 consequences. Similarly, polycomb dependent chromatin compaction in hypomethylated TKO 
706 cells is predicted to be already altered in serum conditions, but, as we have shown, does not 
707 significantly impact on the ability of these cells to transition to a ground state under 2i conditions. 
708 These observations support the idea that DNA methylation and polycomb processes are not 
709 instrumental for the transition of mESCs to a ground state (22,60). It is noteworthy that during 
710 early cleavage-stage mouse embryos, H3K27me3 is absent from promoters under 
711 hypomethylated conditions (43,61). It is only later that bivalent domains (H3K4me3/H3K27me3) 
712 and topological associated domains are newly established in the inner cell mass/trophectoderm, 
713 which constitutes the chromatin environment that supports the gene regulatory networks 
714 necessary for subsequent development (61,62). Our results widen the impact of the observation 
715 that H3K27me3 is dispensable for repression of bivalent genes and de novo silencing in 2i (22).
716
717 DNA methylation regulated gene expression
718 Our data provide a set of core transcriptomic changes that occur independently of methylation in 
719 the conversion of mESCs to the ground state. Despite hypomethylated TKO-serum mESCs 
720 showing some intermediate gene expression states, they firmly cluster with WT-serum mESCs 
721 and have no less requirement for 2i signalling for conversion to a uniform ground state. Our 
722 orthologous experiments demonstrate that constitutive DNA methylation is also not an 
723 impediment to 2i adaptation. The impact of DNA methylation loss at promoter regions is 
724 relatively restricted here, but even at bona fide methylation dependent genes (Dazl and Fkbp6), 
725 their induction in 2i conditions occurs independently of whether their promoters are constitutively 
726 hypomethylated or methylated. The promoter methylation that can be directly overridden in 
727 mESCs contrasts with observations of its inhibitory effect in somatic cells to date, and needs 
728 further investigation of these different cellular contexts (53). Changes in retrotransposon 
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729 expression in response to hypomethylation or 2i signalling are not dramatic in contrast to 
730 retrotransposon derepression in hypomethylated somatic cells, or mESCs defective in Setdb1-
731 dependent histone methylation (30,51,52). Tellingly, neither Prdm14 inactivation in WT cells, 
732 nor its overexpression in TKO mESCs affects 2i mediated transition to the naïve state (36). 
733 Prdm14-/- mESCs in 2i exhibit global levels of DNA methylation comparable to WT mESCs 
734 cultured in serum, which offers strong support that Prdm14 is a key driver of DNA demethylation 
735 in 2i cultures, and not inhibition of Dnmt1 activity by a deficiency of UHRF1 and H3K9me2 
736 factors (20,27,35). Analysis of changes in gene subsets related to stem cell maintenance and cell 
737 fate commitment in microarray data from Prdm14-/- and WT mESCs in 2i with hierarchical 
738 clustering of these datasets are in complete agreement with the present study suggesting that the 
739 role of Prdm14 in antagonising FGFR signalling and repression of de novo Dnmt enzymes maybe 
740 incidental to ground state conversion (20). The characteristic changes that 3B3l mESCs undergo 
741 in 2i in terms of morphology, pluripotency marker homogeneity and gene expression changes in 
742 stem cell maintenance and cell fate commitment gene subsets supports this view. This indicates 
743 that serum/LIF associated patterns of DNA methylation and H3K27me3 are compatible with the 
744 2i state. In addition, OSN enhancers associated with canonical Wnt and ERK signalling pathways 
745 appear to function equivalently in all three epitypes and in the case of 3B3l mESCs did not depend 
746 on Tet mediated demethylation for activity in 2i conditions. We conclude that reorganisation of 
747 core pluripotency factors in 2i is independent of the global epigenetic (DNA methylation and 
748 H3K27me3) state of the cells. 
749 Our results raise new hypotheses regarding the role of DNA methylation and PRC2 
750 (Polycomb Repressive Complex 2) in the 2i transition. In the blastocyst embryo, the early ICM 
751 state exists during a short-lived window in the lead-up to embryonic differentiation or the 
752 derivation of mESC lines, which are thought to acquire late epiblast characteristics in in vitro 
753 cultures (9). This is accompanied by higher levels of DNA methylation, more restricted Prdm14 
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754 expression, fluctuating pluripotency gene expression and emergence of differentiation marks and 
755 heterochromatin maturation marks as well as a shorter cell cycle time (10,63). From this 
756 perspective, the conversion of serum mESCs to 2i conditions can be regarded as a reprogramming 
757 of these cells to an earlier pluripotent state, which does not maintain these late markers, but their 
758 presence is not a hindrance to regaining a 2i mediated ground state. This may be especially 
759 relevant to redefining the hallmarks of naïve pluripotency in other mammals that may have 
760 distinct developmental epigenetic reprogramming patterns (14). In mouse early preimplantation 
761 embryos, a state of low DNA methylation is actively and passively maintained through 
762 mechanisms of DNA demethylation, Dnmt1 exclusion, cell division, and Prdm14 expression, 
763 while chromatin is dynamic and more dispersed (61,62,64). The organisation of condensed 
764 chromatin domains and chromocenters appears after implantation and also in epiblast stem cells, 
765 for which DNA methylation is required (64). 
766 We propose that global hypomethylation is a consequence of transcriptional and 
767 signalling changes in 2i medium, but is not essential for adaptation of mESCs to the 
768 “transcriptional ground state” as defined by core transcription changes that occur irrespective of 
769 methylation in the conversion of mESCs to the ground state. This implies that signalling induced 
770 gene regulatory networks, and not epigenetic mechanisms, dominate to regulate transcriptional 
771 changes required for mESCs to achieve ground state. This is compatible with studies showing 
772 that inactivation of many epigenetic regulators (Ezh2, Eed, Dnmt1, Uhrf1, Ring1b, G9a, Glp, 
773 (Suv39h1 and Suv39h2), Jarid1b and Tet1-3) is compatible with development up to blastocyst 
774 stages and derivation of self-renewing mESCs but incompatible with later stages of development 
775 when pluripotency networks are attenuated and alternative differentiation associated GRNs are 
776 prominent (65). It is clear that altered patterns of DNA methylation and polycomb in the naive 
777 state do not define its identity through gene regulation but may reflect genomic reprogramming 
778 to earlier patterns present in pre-blastocyst embryos, with 2i conditions reversing chromatin 
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779 transitions that may develop into the epigenetic control of gene expression in differentiated cells. 
780 A key question is, when do these repressive epigenetic pathways become operational and possibly 
781 outweigh signalling cues, and what roles do these early transitions play in subsequent 
782 differentiation to stable somatic lineage identities. It is plausible that this is linked with core 
783 transcription factor changes enabling essential regulatory roles for epigenetic processes in 
784 coordinating and maintaining differential patterns of gene expression.
785
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1042 Fig. 1. J1, TKO and 3B3l mESCs achieve ground state in 2i.
1043 a, Schematic showing cell line derivation. An expression construct for the co-factor Dnmt3l was 
1044 added to Dnmt3a/3b knockout mESCs rescued by exogenous constitutive expression of Dnmt3b 
1045 (3B) to create a Dnmt3a/3b knockout expressing both Dnmt3l and Dnmt3b (3B3l). Dnmt3l was 
1046 also added to a to Dnmt3a/3b knockout mESCs (KOVI) to create KOVI-3l. b, Morphology 
1047 images of mESCs in indicated culture conditions. Scale bar 100m. c, Expression levels of 
1048 indicated Dnmt’s and Prdm14. For each gene, fold change with respect to (wrt) average J1-serum 
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1049 probe value is represented (as log2) with SEMs. * indicates p < 0.05 (unpaired t-test). d, 
1050 Immunocytochemistry images of indicated conditions showing Nanog (green) and Esrrb (red) 
1051 with DNA counterstaining (DAPI, blue) and merge. Scale bar 100m. e, HPLC quantification of 
1052 5mC levels of indicated mESCs, bars represent mean ± SD of 2-3 biological replicates. f, Bisulfite 
1053 sequencing data for indicated gene promoters and cell lines, black: methylated CpG, grey: un-
1054 methylated CpG, white: missing data. Numbers represent percentage of methylated CpGs. * 
1055 (black: methylated CpG, grey: un-methylated CpG, white: missing data). *p < 0.05, ** p = 
1056 0.00578, 2-tailed Mann-Whitney U-Test.
1057
1058 Fig. 2. Epigenetic state of heterochromatin in mESCs and H3K27me3 dynamics during 
1059 mouse blastocyst development.
1060 a-b, ICC of H3K27me3 (green) and H2AK119Ubiquitin (green) in indicated cells with DAPI 
1061 (blue) and merge (turquoise represents overlapping signal). White outlined nuclei are ‘zoomed 
1062 in’ images of representative nuclei. Numbers represent the percentage of cells where green foci 
1063 overlap with DAPI stained heterochromatin. Scale bar 50m. c, ICC for H3K27me3 (green) with 
1064 DAPI (pseudocoloured red). Whole and part embryo confocal projections and highlighted cells 
1065 from the inner ICM and the ICM margin (yellow represents overlapping signal), as indicated; 
1066 scale bars 10m. Arrowheads indicate three cells showing heterochromatic H3K27me3 staining.
1067
1068 Fig. 3. Gene expression changes in mESCs upon culturing in 2i.
1069  a, Heatmap showing Pearson correlation and clustering of microarray data for indicated cell lines 
1070 and culture conditions. b, Venn diagram showing the number of genes changing in expression 
1071 (FC  2, p.adj.  0.05 eBayes (limma), Benjamini-Hochberg corrected) in J1-2i (red), TKO-2i 
1072 (green) and 3B3l-2i (yellow) compared to their serum counterparts. c, Log2 expression values of 
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1073 indicated genes in mESCs in serum and 2i. Bars represent mean ± SD. * indicates p < 0.05 
1074 (unpaired t-test). d, GO-Term analysis showing genes up- or down-regulated in J1, TKO and 
1075 3B3l mESCs. e, Heatmap representing expression levels of ‘Cell Fate Commitment’ genes 
1076 differentially expressed (FC ≥ 1.5, p.adj. ≤ 0.05 eBayes (limma), Benjamini-Hochberg corrected) 
1077 in J1-2i compared to J1-serum in indicated cells. * marks genes which are differentially expressed 
1078 (FC  2, p.adj.  0.05 eBayes (limma), Benjamini-Hochberg corrected) between TKO-serum and 
1079 J1-serum. f, Same as e for ‘Stem Cell Maintenance’ genes.
1080
1081 Fig. 4. 5mC and H3K27me3 modifications in J1, 3B3l and TKO mESCs in serum and 2i. 
1082 a, Windows enriched in 5mC relative to input sequence for indicated cell lines and conditions. b, 
1083 Fluorescent western blot of whole cell protein extracts showing levels of H3K27me3 for indicated 
1084 cell lines cultured in serum or 2i. β-tubulin was used as a loading control. c, Total number of 
1085 5mC peaks (see materials and methods) for indicated cell lines and conditions. d, Heatmap 
1086 indicating 5mC (red) and H3K27me3 (purple) levels; 0-10, see scale, for indicated cell lines and 
1087 conditions across indicated genomic features, covering regions as described. Q4-Q1 indicates 
1088 low to high gene expression. e, Sliding window analysis of average genic 5mC patterns across 
1089 indicated cell lines. Plots represent length normalised gene bodies with flanking regions (+/-25% 
1090 of total gene length). Stratification of genic patterns by promoter 5mC enrichment (upper box) or 
1091 depletion (lower box). Numbers of genes per set are shown above. f, Boxplots representing 
1092 average H3K27me3 signal on promoters (+/- 1kb from TSS) for all promoters or promoters 
1093 preferentially losing H3K27me3 in TKO-2i relative to TKO-serum. * indicates p < 0.05 
1094 (Wilcoxon test). g, Heatmap representing normalised H3K27me3 reads across promoters (+/- 5kb 
1095 TSS). Bottom graphs represent averaged profiles. Heatmaps are ranked by E14 serum levels. h, 
1096 Examples of H3K27me3 pattern across Neurog3, Hoxc13, 12, 11 and Tbx3 for indicated cell lines 
1097 and culture conditions.
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1098
1099 Fig. 5. Epigenetic changes over transcriptionally altered genes in mESCs in serum and 2i.
1100 a, Boxplots of average promoter 5mC in indicated cell lines over the total gene set, genes 
1101 expressed under 2i conditions and genes repressed under 2i conditions. * indicates p < 0.05 
1102 (Wilcoxon test). b, Examples of 5mC data at the promoters of the methylation regulated genes 
1103 Dazl and Fkbp6 alongside RT-qPCR data for serum and 2i conditions. Promoter regions are 
1104 marked by grey shadows. Barcharts show expression analysis of indicated genes by RT-qPCR, 
1105 values represent mean ± SD of expression with respect to (wrt) TBP. * indicates p < 0.05 
1106 (unpaired t-test). c, Scatter plot of fold change in expression 2i-serum (y-axis) versus fold change 
1107 in average genic H3K27me3 levels (2i-serum) in WT (left), 3B3l (centre) and TKO (right) cells. 
1108 Yellow = 2i induced genes, blue = 2i repressed genes. d, Boxplot detailing expression changes 
1109 serum to 2i (log2 fold changes) across WT, TKO, 3B3l, Eed-/- and EPZ6438 treated Dnmt1tet/tet 
1110 mESCs. Left: genes with overlapping H3K27me3 loss/expression gain in J1/TKO/3B3l mESCs. 
1111 Right: genes with overlapping H3K27me3 gain/expression loss in J1/TKO/3B3l mESCs.
1112
1113 Fig. 6. Relationship between, gene regulatory networks, epigenetic marks and culture 
1114 conditions in mESCs. 
1115 a,  Z-score normalised heatmaps ranked by relative expression level of the nearest gene to an 
1116 OSN binding site (within +/-10kb) with increased binding in 2i (top) or increased binding in 
1117 serum (bottom) for indicated cell lines. Hierarchical clustering groups by culture condition. (b-c) 
1118 siRNA knockdown of Tet1 and Tet2 for indicated cell lines. b, Immunocytochemistry for 
1119 indicated cell lines. Scale bar is 100m. Left: DAPI (blue), 5hmC (green) and merge. Right: 
1120 DAPI (blue), Esrrb (green), Tet1 (yellow), Cy3-siRNA (red) and merge. c, Expression analysis 
1121 of indicated genes by RT-qPCR in J1-36 (blue) and 3B3l (orange) mESCs in 72h serum or 48h 
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43
1122 serum + 24h 2i transfected with either scrambled siRNA or siRNAs for Tet1 + Tet2. Values 
1123 represent mean +/- S.D. of three technical replicates with respect to (wrt) to the housekeeping 
1124 gene TBP (TATA Binding Protein), normalised to serum siScrambled values. 
1125
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 Figure 1: J1, TKO and 3B3l mESCs achieve ground state in 2i. 
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 Figure 2: Epigenetic state of heterochromatin in mESCs and H3K27me3 dynamics during mouse blastocyst 
development. 
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 Figure 3: Gene expression changes in mESCs upon culturing in 2i. 
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 Figure 4: 5mC and H3K27me3 modifications in J1, 3B3l and TKO mESCs in serum and 2i. 
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 Figure 5: Epigenetic changes over transcriptionally altered genes in mESCs in serum and 2i. 
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 Figure 6: Relationship between, gene regulatory networks, epigenetic marks and culture conditions in 
mESCs 
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Figure S8: Genome wide analysis of 5mC and H3K27me3 peak distribution in mESCs in 
serum and 2i. 
a, Plot of the distribution of 5mC and H3K27me3 peaks for indicated cell lines and conditions, 
promoters (TSS +/-1kb: blue), genie (orange), inter-genie (grey). b, Heatmap indicating 5mC (red) 
and H3K27me3 (purple), levels; 0-10, see scale, for indicated cell lines and conditions across pluri­
potency transcription factor binding elements, Oct4, Sox2 and Nanog, + / -  10kb. c, Boxplot showing 
changes in the abundance (Log2FC: log2 fold change) of retrotransposon RNAs (LINE, SINE and 
LTR Repeatmasker classes) in the indicated comparisons between cell lines and conditions. d-e, 
Overlaps between sets up retrotransposons upregulated (logFC > 0 and FDR< 0.05) in the indicat­
ed comparisons. f, Behaviour of selected retrotransposon RNAs between the indicated cell lines 
and conditions. Mean RNA abundance (CPM, counts per million mapped reads) and standard 
deviation between three replicates for each sample are indicated. Signalling responsive retrotrans­
posons are upregulated in 2i in J1, TKO and 3B3I cells, i.e. regardless of the methylation state of 
the cell line. Methylation responsive retrotransposons are upregulated in hypomethylated (TKO) 
mESCs in serum relative to J1 mESCs in serum, but not in 3B3I cells in response to 2i. Retrotrans­
posons responding to 2i conditions and to the methylation state of the cell are upregulated in 2i in 
J1, TKO and 3B3I cells, but the level of retrotransposon expression is affected by the methylation 
state of the cell (i.e. upregulated in TKO cells relative to 3B3I cells). Some of the retrotransposons 
identified in this analysis (RLTR13B2::EtnERV3-int, RLTR44C::RLTR44-int, RLTR10D::IAP-d-int) 
correspond to long terminal repeats and their cognate adjacent internal sequences that they can be 
found flanking in the mouse genome. 



